Marex Group’s cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock YCBD.PRA Stock Holding History

Marex Group’s Portfolio YCBD.PRA Stock Details YCBD.PRA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$222K	Buy
2024 Q4	$64.6K	Buy
2024 Q3	$37.6K	Buy
2024 Q2	$24.3K	Sell
2024 Q1	$33.7K	Buy
2023 Q4	$7.86K	Buy